Fennec Pharmaceuticals Inc. (FENC) News
Filter FENC News Items
FENC News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
FENC News Highlights
- For FENC, its 30 day story count is now at 2.
- Over the past 1 day, the trend for FENC's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- The most mentioned tickers in articles about FENC are DEC.
Latest FENC News From Around the Web
Below are the latest news stories about FENNEC PHARMACEUTICALS INC that investors may wish to consider to help them evaluate FENC as an investment opportunity.
With 31% stake, Fennec Pharmaceuticals Inc. (NASDAQ:FENC) seems to have captured hedge funds investors' interestKey Insights Institutions' substantial holdings in Fennec Pharmaceuticals implies that they have significant influence... |
Fennec Announces Incremental $5 Million Investment from Petrichor~ Supports Strategic Discussions and Global Launch Activities ~ ~ Extends Access to Additional Undrawn Capital As Needed During Global PEDMARK® Rollout ~ ~ Facilitates Market Expansion into the Adolescent and Young Adult (AYA) Patient Population ~ RESEARCH TRIANGLE PARK, N.C., Dec. 05, 2023 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company focused on improving the lives of children with cancer, today announced the third |
Fennec Pharmaceuticals to Participate in Upcoming Investor ConferencesRESEARCH TRIANGLE PARK, N.C., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the Company will be participating in upcoming conferences. The management team will also host one-on-one investor meetings at the conferences. Presentation Details: Event: Jefferies London Healthcare Conference in London, UKDate: November 16, 2023Time: Company Presentation at 5:00 a.m. ET / 10:00 a.m. GMT Ev |
Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Reported Earnings Last Week And Analysts Are Already Upgrading Their EstimatesA week ago, Fennec Pharmaceuticals Inc. ( NASDAQ:FENC ) came out with a strong set of quarterly numbers that could... |
Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q3 2023 Earnings Call TranscriptFennec Pharmaceuticals Inc. (NASDAQ:FENC) Q3 2023 Earnings Call Transcript November 6, 2023 Fennec Pharmaceuticals Inc. beats earnings expectations. Reported EPS is $-0.07, expectations were $-0.11. Operator: Good morning, ladies and gentlemen, and welcome to Fennec Pharmaceuticals Third Quarter 2023 Earnings and Corporate Update Conference Call. At this time, all participants are in a listen-only mode. […] |
Q3 2023 Fennec Pharmaceuticals Inc Earnings CallQ3 2023 Fennec Pharmaceuticals Inc Earnings Call |
Fennec Pharmaceuticals Announces Third Quarter 2023 Financial Results and Provides Business Update~ PEDMARK® Net Product Revenue of $6.5 Million, a 96% Increase Compared to Second Quarter ~ ~ Strong Commercial Uptake Underscoring Significant Unmet Medical Need ~ ~ Received Approval in October 2023 by the Medicines and Healthcare Products Regulatory Agency (MHRA) in the U.K. for PEDMARQSI ~ ~ Management to Host Conference Call Today at 8:30 a.m. ET ~ RESEARCH TRIANGLE PARK, N.C., Nov. 06, 2023 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a commercial stage specialt |
Investors in Fennec Pharmaceuticals (NASDAQ:FENC) have unfortunately lost 20% over the last yearIt's easy to match the overall market return by buying an index fund. Active investors aim to buy stocks that vastly... |
Fennec Pharmaceuticals to Report Third Quarter 2023 Financial Results on November 6, 2023RESEARCH TRIANGLE PARK, N.C., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the Company will release its third quarter 2023 financial results before the opening of the U.S. financial markets on Monday, November 6, 2023. Management will host a conference call and webcast that day to discuss the Company’s financial and business results. Conference Call & Webcast Detail: Date: Monday, |
Analysts Expect Breakeven For Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Before LongFennec Pharmaceuticals Inc. ( NASDAQ:FENC ) is possibly approaching a major achievement in its business, so we would... |